NC
KURA icon

Nexthera Capital’s Kura Oncology KURA Stock Holding History

Nexthera Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-311,536
Closed -$5.45M – 35
2018
Q3 		$5.45M Sell
311,536
-69,923
-18% -$1.34M 1.04% 25
2018
Q2 		$6.94M Buy
381,459
+29,504
+8% +$500K 1.07% 26
2018
Q1 		$6.6M Sell
351,955
-93,595
-21% -$1.82M 1.09% 27
2017
Q4 		$6.82M Buy
445,550
+187,034
+72% +$2.76M 1.26% 24
2017
Q3 		$3.87M Buy
+258,516
New +$2.43M 0.99% 27

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Nexthera Capital's KURA Position: Q4 2018 in Review

Nexthera Capital sold out of Kura Oncology (KURA) in Q4 2018, closing a stake of 311,536 shares — an estimated $5.45M sold.

Nexthera Capital first reported a position in KURA in Q3 2017 and held it in 5 quarters. The position peaked at $6.94M in Q2 2018. 99 funds tracked by Wall St. Rank hold KURA as of Q4 2018.

  • Nexthera Capital reported no remaining Kura Oncology position as of Q4 2018 after selling out during the quarter.
  • Nexthera Capital sold 311,536 Kura Oncology shares in Q4 2018, an estimated $5.45M.
  • Nexthera Capital first reported a position in Kura Oncology in Q3 2017 and held it in 5 quarters.
  • Nexthera Capital's Kura Oncology position peaked at $6.94M in Q2 2018.
  • 99 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2018.

Based on Nexthera Capital's 13F filing for Q4 2018, filed 14 Feb 2019.